CT
GILD icon

Colonial Trust’s Gilead Sciences GILD Stock Holding History

Colonial Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.9K Sell
649
-24
-4% -$3.16K 0.01% 435
2026
Q1 		$93.8K Sell
673
-190
-22% -$26.6K 0.01% 430
2025
Q4 		$106K Buy
863
+46
+6% +$5.59K 0.01% 413
2025
Q3 		$90.7K Buy
817
+93
+13% +$10.6K 0.01% 459
2025
Q2 		$80.3K Sell
724
-1
-0.1% -$106 0.01% 471
2025
Q1 		$81.3K Sell
725
-63
-8% -$6.5K 0.01% 455
2024
Q4 		$72.8K Buy
788
+217
+38% +$19.5K 0.01% 499
2024
Q3 		$47.8K Buy
571
+68
+14% +$5.19K 0.01% 556
2024
Q2 		$34.5K Sell
503
-66
-12% -$4.4K 0.01% 572
2024
Q1 		$41.7K Buy
569
+7
+1% +$538 0.01% 541
2023
Q4 		$45.5K Sell
562
-119
-17% -$9.26K 0.01% 519
2023
Q3 		$51.1K Buy
681
+250
+58% +$19.2K 0.01% 477
2023
Q2 		$32.7K Buy
431
+26
+6% +$2.07K 0.01% 534
2023
Q1 		$33K Buy
405
+19
+5% +$1.57K 0.01% 520
2022
Q4 		$32.9K Buy
+386
New +$30.6K 0.01% 505

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Colonial Trust's GILD Position: Q2 2026 in Review

Colonial Trust reduced its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, selling an estimated $3.16K and leaving 649 shares worth $81.9K. The position accounts for 0.01% of the portfolio, ranked #435.

Colonial Trust first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $106K in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Colonial Trust held 649 shares of Gilead Sciences worth $81.9K as of Q2 2026.
  • Colonial Trust sold 24 Gilead Sciences shares in Q2 2026, an estimated $3.16K.
  • Gilead Sciences made up 0.01% of Colonial Trust's portfolio in Q2 2026, its #435 holding.
  • Colonial Trust first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Colonial Trust's Gilead Sciences position peaked at $106K in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.